2019
DOI: 10.32098/mltj.04.2015.02
|View full text |Cite
|
Sign up to set email alerts
|

Hyaluronic acid and tendon lesions

Abstract: Hyaluronic acid and tendon lesions by limited but encouraging short-term clinical results on pain and function. However, controlled randomised studies are still needed.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
44
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
4
3

Relationship

1
6

Authors

Journals

citations
Cited by 43 publications
(46 citation statements)
references
References 40 publications
0
44
0
Order By: Relevance
“…), others remain chronic. It is for this reason that a lot of research has been carried out to develop or adapt treatments for such rebel conditions, among which PRP and HA (13,28). Some clinical studies have previously evaluated the effect of PRP in the treatment of proximal patellar tendinopathies (6,23,24,29).…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations
“…), others remain chronic. It is for this reason that a lot of research has been carried out to develop or adapt treatments for such rebel conditions, among which PRP and HA (13,28). Some clinical studies have previously evaluated the effect of PRP in the treatment of proximal patellar tendinopathies (6,23,24,29).…”
Section: Discussionmentioning
confidence: 99%
“…Even if this treatment remains controversial in the literature, recent systematic reviews have concluded that PRP could be recommend (low evidences) as a treatment in such indications (8)(9)(10)(11)(12). The use of HA in the treatment of tendinopathies is even more recent in clinical practice, even if pre-clinical studies in the healing process of tendons have been reported in the past 20 years (13,14,30). However, it seems that HA injections have been effective in small groups of patients with tendinopathies (13).…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Hyaluronic acid is a linear, anionic, nonsulfated glycosaminoglycan with unique characteristics. HA molecules are polymers of disaccharides (up to 25000 disaccharide repeat units in length) composed of D-glucuronic acid and N-acetyl-D-glucosamine, linked via alternating β(1→4) and β(1→3) glycosidic bonds (7).…”
Section: Introductionmentioning
confidence: 99%